Seelos Therapeutics, Inc. (SEEL) NASDAQ
0.37
+(+%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 865.58M |
| Enterprise Value | 876.81M |
| P/E Ratio | -0.05 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.1 |
| Price/Book Ratio | -0.05 |
| Enterprise/Revenue | 5.2 |
| Enterprise/EBITDA | -0.3 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | June 30, 2024 |
Profitability
| Profit Margin | -17.2 |
| Operating Margin | -18.38 |
Management Effectiveness
| Return On Assets | -6.99 |
| Return On Equity | 1.72 |
Income Statement
| Revenue | 2.2M |
| Revenue/Share | 0.45 |
| Gross Profit | -27.91M |
| EBITDA | -37.75M |
| Net Income | -37.88M |
| Diluted EPS | -7.73 |
Balance Sheet
| Total Cash | 294,000 |
| Total Cash/Share | 0.61 |
| Total Debt | 10.16M |
| Total Debt/Equity | -0.42 |
| Current Ratio | 0.14 |
| Book Value Per Share | -6.84 |
Price History
| 52-Week Change | -99.82 |
| 52-Week High | 0.37 |
| 52-Week Low | 0.37 |
| Moving Average 50 Days | 0 |
| Moving Average 200 Days | 0 |
Statistics
| Average Volume | 0 |
| Shares Outstanding | 581,000 |
| % Held by Institutions | 2.38 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | September 27, 2024 |
